H&T Presspart is pleased to announce we will be a Platinum sponsor at this year’s DDL 2024 (Drug Delivery to the lungs) which is once again being held in Edinburgh from the 11-13 December, 2024.

As Platinum sponsors, H&T Presspart will also be exhibiting at the conference on stand 165, where visitors can learn about our range of inhalation components and devices including MDI cans and actuators, as well as our range of dry powder inhalers.

As a market leader in the design and manufacture of inhalation drug delivery components and devices, the H&T Presspart team will also be on hand to discuss how we can support our customers transition to the next generation low GWP propellants, including our filling capabilities in GMP conditions to support development programs and clinical trials with both HFA-152a and HFO-1234ze propellants

In the scientific poster area, you will be able to view a poster submitted by our Inhalation Product Technology team entitled ‘A Tale of 3 Propellants: Understanding the In-Vitro Characteristics of a Solution pMDI’.

The Drug Delivery to the Lungs Conference (DDL), which will be celebrating its 35th year, attracts in excess of 1000 attendees worldwide, including scientists, academics, clinicians, regulators and industry experts. The conference includes a large industry exhibition, supported by over 100 international companies, a scientific poster hall, expert lectures and excellent networking opportunities over the 3-day event. DDL actively supports young scientists by offering free registration for students, Career Development Grants and a variety of awards, recognising their achievements.

If you are attending the conference and would like to arrange a meeting then please contact the H&T Presspart team.